top of page
Incubate Releases Statement on Trump Administration's "Most Favored Nation" Pricing Deal
WASHINGTON ( Sep 30 ) -- Today, the Trump administration announced its first agreement with a manufacturer to bring most-favored-nation...
Incubate Coalition
Oct 2
Incubate Releases Statement on New Most Favored Nation Pricing Deadline
WASHINGTON, D.C. ( July 31 ) -- Today, the Trump administration announced a 60-day deadline for 17 leading pharmaceutical manufacturers...
Incubate Coalition
Jul 30
Incubate Joins Punchbowl News, Rep. Greg Murphy to Discuss the Future of Medicine
On June 24, Incubate executive director John Stanford joined Punchbowl News for a discussion on the future of medicine. The culmination...
Incubate Coalition
Jun 30
The Consequences of Most Favored Nation Drug Pricing Model for Patients and Innovation
The White House and some members of Congress have recently proposed adopting a "Most Favored Nation" (MFN) pricing model for Medicaid...
Incubate Coalition
Jun 11
bottom of page